| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Atkore International Group (TBA) | Credit Suisse/ Deutsche Bank Securities/ J.P. Morgan/ UBS Investment Bank | $100.00 | n.a. | |||
| Hunting Dog Capital (HDCC) | W. R. Hambrecht + Co. | $50.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| Advanced Inhalation Therapies (AITPU) (u) | Joseph Gunnar & Co. | 0.33 | $15.00 | $15.00 | $5.00 | 1-Star |
| Withdrawn | ||||||
| PLx Pharma (PLXP) | Raymond James/ Maxim Group LLC | 3.80 | $17.00 | $19.00 | $68.40 | 1-Star |
| New Terms | ||||||
| BioLight Life Sciences Ltd. (BOLT) | Feltl and Company/ Rodman & Renshaw a unit of H.C. Wainwright & Co.) | 1.85 | $5.86 | $5.86 | $10.83 | N/C (A) |
| Hutchison China MediTech (HCM) | BofA Merrill Lynch/ Deutsche Bank Securities | 6.12 | $16.33 | $16.33 | $100.00 | N/C (B) |
| KLR Energy Acquisition (KLREU) | EarlyBirdCapital | 10.00 | $10.00 | $10.00 | $100.00 | 1-Star |
| N/C (A) = No Call – Stock is traded on the Tel Aviv Stock Exchange | ||||||
| N/C (B) = No Call – Stock is traded on the AIM market of the London Stock Exchange | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 29, 2016 | Manager(s) | Offered | Raised | Price | 3/4/16 | Change |
| Jensyn Acquisition (JSYNU) (u) | Chardan Capital Markets | 3.90 | $39.00 | $10.00 | $9.98 | -0.20% |
| Syndax Pharmaceuticals (SNDX) | Morgan Stanley/ Citigroup | 4.40 | $52.80 | $12.00 | $11.85 | -1.25% |
| u (unit offering) | ||||||
